Mangoceuticals, Inc.
MGRX- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001938046
No open-market purchases or sales by Mangoceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $455.6K in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Mangoceuticals, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 6 | 13 | +7 |
| Shares | 483.5K | 1.36M | +873.2K (+180.6%) |
| Value | $147.7K | $319.7K | +$172.1K (+116.5%) |
New holders (11)
Institutions that held Mangoceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ackerman Capital Advisors, LLC | 873,356 | $206.1K | 0.05% |
| Geode Capital Management, LLC | 131,327 | $31.0K | 0.00% |
| McCollum Christoferson Group LLC | 85,800 | $20.2K | 0.01% |
| Two Sigma Securities, LLC | 37,845 | $8.93K | 0.00% |
| Steward Partners Investment Advisory, LLC | 31,400 | $7.41K | 0.00% |
| XTX Topco Ltd | 28,830 | $6.80K | 0.00% |
| Creative Planning | 20,000 | $4.72K | 0.00% |
| Captrust Financial Advisors | 17,077 | $4.03K | 0.00% |
| StoneX Group Inc. | 13,647 | $3.22K | 0.00% |
| Goldman Sachs Group Inc | 10,187 | $2.40K | 0.00% |
| Bank of America Corp | 156 | $37 | 0.00% |
Sold out (4)
Institutions that held Mangoceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Citadel Advisors LLC | 133,195 | $41.2K |
| Mercer Global Advisors Inc | 100,000 | $30.4K |
| UBS Group AG | 52,944 | $16.1K |
| Morgan Stanley | 10,358 | $3.15K |